Related Experiment Video
Updated: Apr 11, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.9K
Treatment dilemmas in chronic urticaria
G Sussman1, M Gonçalo2, M Sánchez-Borges3
1Division of Allergy and Clinical Immunology, St. Michael's Hospital and University of Toronto, Toronto, ON, Canada.
Summary
Updated clinical guidelines for chronic urticaria (CU) offer practical strategies for diagnosis and management. This article illustrates implementing these recommendations through diverse patient case studies.
Area of Science:
- Allergy and Clinical Immunology
- Dermatology
- Public Health
Background:
- The European Academy of Allergy and Clinical Immunology (EAACI), Global Allergy and Asthma European Network (GA(2) LEN), European Dermatology Forum (EDF), and World Allergy Organization (WAO) have released updated recommendations.
- These guidelines address the classification, diagnosis, and management of chronic urticaria (CU).
Observation:
- The article presents several case histories detailing the application of these new recommendations.
- These cases represent a variety of real-life patient scenarios encountered in clinical practice.
Findings:
- The case studies demonstrate practical implementation of the updated EAACI/GA(2) LEN/EDF/WAO guidelines for chronic urticaria.
- Successful treatment strategies for diverse CU patient profiles are illustrated.
Implications:
- These case examples can guide clinicians in applying the latest evidence-based approaches to chronic urticaria management.
- Improved patient outcomes in chronic urticaria are anticipated through adherence to standardized diagnostic and therapeutic protocols.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
01:30Hypersensitivities
8.5K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.5K
01:26Peptic Ulcer Disease IV: Management
669
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
669
01:19Antiasthma Drugs: Leukotriene Modifiers
2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.3K
01:27Acne Infection
64
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
64
01:17Drugs for Treatment of Diarrhea-Predominant IBS
905
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
905